Progress in the research on multi-target-directed drugs against Alzheimer's disease / 药学学报
Acta Pharmaceutica Sinica
;
(12): 258-263, 2009.
Artículo
en Chino
| WPRIM
| ID: wpr-278273
ABSTRACT
Alzheimer's disease (AD) is a chronic neurodegenerative disorder and one of the earliest sings of AD is deficit in short term memory. Till now, the pathogenesis of AD has not been elucidated and the present one-drug-one-target paradigm of anti-AD-drug treatment seems not to be effective in clinic. Multi-target-directed anti-AD-drugs are those agents that may act on two or more targets implicated in AD. Based on the brief introduction of progress in the development of present anti-AD-drugs, the paper mainly focused on the advances in the field of multi-target-directed drug development both home and abroad, especially those studies on selective estrogen receptor modulators.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Tacrina
/
Medicamentos Herbarios Chinos
/
Ácido Tióctico
/
Sistemas de Liberación de Medicamentos
/
Moduladores Selectivos de los Receptores de Estrógeno
/
Usos Terapéuticos
/
Combinación de Medicamentos
/
Quimioterapia
/
Enfermedad de Alzheimer
/
Indanos
Límite:
Animales
/
Humanos
Idioma:
Chino
Revista:
Acta Pharmaceutica Sinica
Año:
2009
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS